Ergomimet en es it fr

Ergomimet Brand names, Ergomimet Analogs

Ergomimet Brand Names Mixture

  • No information avaliable

Ergomimet Chemical_Formula

C33H37N5O5

Ergomimet RX_link

http://www.rxlist.com/cgi/generic2/dihyergmes.htm

Ergomimet fda sheet

Ergomimet FDA

Ergomimet msds (material safety sheet)

Ergomimet MSDS

Ergomimet Synthesis Reference

No information avaliable

Ergomimet Molecular Weight

583.678 g/mol

Ergomimet Melting Point

No information avaliable

Ergomimet H2O Solubility

No information avaliable

Ergomimet State

Solid

Ergomimet LogP

No information avaliable

Ergomimet Dosage Forms

Liquid

Ergomimet Indication

For the acute treatment of migraine headaches with or without aura and the acute treatment of cluster headache episodes.

Ergomimet Pharmacology

Dihydroergotamine is indicated for the acute treatment of migraine headaches with or without aura and the acute treatment of cluster headache episodes. Dihydroergotamine binds with high affinity to 5-HT1Da and 5-HT1Db receptors. It also binds with high affinity to serotonin 5-HT1A, 5-HT2A, and 5-HT2C receptors, noradrenaline a2A, a2B and a receptors, and dopamine D2L and D3 receptors. The therapeutic activity of Dihydroergotamine in migraine is generally attributed to the agonist effect at 5-HT1D receptors.

Ergomimet Absorption

Interpatient variable and may be dependent on the administration technique

Ergomimet side effects and Toxicity

Side effects include abdominal pain, abnormal speech, coma, confusion, convulsions, hallucinations, increase and/or decrease in blood pressure, nausea, numbness, tingling, pain, and a bluish color of your fingersand toes, slowed breathing, vomiting

Ergomimet Patient Information

PATIENT INFORMATIOn

Follow the link below to get detailed information before taking D.H.E. 45 (dihydroergotamine mesylate) Injection.

http://www.rxlist.com/cgi/generic2/dihyergmes_pi.htm

Ergomimet Organisms Affected

Humans and other mammals